[1]
“Use of Valproic acid and Cannabis sativa in the pharmacotherapeutic response to the treatment of epilepsy: a literature review”, RSD, vol. 11, no. 14, p. e522111436600, Nov. 2022, doi: 10.33448/rsd-v11i14.36600.